Different requirements for alpha-galactosylceramide and recombinant IL-12 antitumor activity in the treatment of C-26 colon carcinoma hepatic metastases.

Source:http://linkedlifedata.com/resource/pubmed/id/11592087

Download in:

View as

General Info

PMID
11592087